Endocrine Abstracts

Objectives: To assess baseline differences on lipid profile in individuals with gender identity disorder (male to female, M2F and female to male, F2M) in relation to prior cross-sex hormone treatment (CHT) or not, and changes in the lipid profile after 24 months of treatment and follow-up in our unit.Methods: Transversal study by revision of medical records of 235 patients visited for first time in our service from 2006 to 2010. Clinical and analytical r...

Introduction: Previous studies indicate a high prevalence of HIV infection in the transgender population and associate it with sexual risk behavior, psychiatrical and socio-economic problems. Anyway, few data are available regarding other factors. We assessed the prevalence of HIV and other associated characteristics in a transgender population of Catalonia.Methods: Cross-sectional study including 234 transsexuals that started follow-up in a reference ce...

Objectives: Most transgender persons (0.3-0.5% of total population) are under gender-affirming hormone therapy (GAHT). Several studies have reported an increased morbimortality due to cardiovascular events (CVE), infectious disease and suicide. However, these studies were made on small populations and short follow up. We evaluated the changes on anthropometric variables, risk factors for cardiovascular diseases (CVD) and CVE at 5 and 10 years of follow up in a transgender popu...